Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Seagen Inc.
SystImmune Inc.
Toray Industries, Inc
National Cancer Institute (NCI)
Hoffmann-La Roche
ADC Therapeutics S.A.
Celldex Therapeutics
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Abramson Cancer Center at Penn Medicine
Celgene
Critical Outcome Technologies Inc.
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
AbbVie
Santa Maria Biotherapeutics
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health